A retrospective study of efficacy of glecaprevir plus pibrentasvir in chronic hepatitis C patient who failed to respond during prior DAA therapies
Latest Information Update: 07 Jul 2020
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
Most Recent Events
- 07 Jul 2020 New trial record